{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:28:51Z","timestamp":1783074531631,"version":"3.54.6"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Key Programs of Mega Infectious Diseases","award":["2013ZX10003002-001"],"award-info":[{"award-number":["2013ZX10003002-001"]}]},{"name":"Key Project of the State Key Laboratory for Infectious Disease Prevention and Control","award":["2014SKLID104"],"award-info":[{"award-number":["2014SKLID104"]}]}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ijantimicag.2016.10.024","type":"journal-article","created":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T07:32:12Z","timestamp":1482305532000},"page":"364-374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria"],"prefix":"10.1016","volume":"49","author":[{"given":"Guilian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzhi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haican","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanglin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1128\/CMR.9.2.177","article-title":"Epidemiology of infection by nontuberculous mycobacteria","volume":"9","author":"Falkinham","year":"1996","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0272-5231(02)00014-X","article-title":"Nontuberculous mycobacteria in the environment","volume":"23","author":"Falkinham","year":"2002","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0020","author":"LPSN bacterio.net"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1440-1843.2008.01408.x","article-title":"When and how to treat pulmonary non-tuberculous mycobacterial diseases","volume":"14","author":"Thomson","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0030","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1128\/CMR.16.2.319-354.2003","article-title":"Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s","volume":"16","author":"Tortoli","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0035","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1056\/NEJMoa012643","article-title":"An outbreak of mycobacterial furunculosis associated with footbaths at a nail salon","volume":"346","author":"Winthrop","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0040","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.1016\/j.ijid.2012.12.011","article-title":"The first case of pulmonary disease caused by Mycobacterium septicum in China","volume":"17","author":"Lian","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0045","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0050","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1111\/j.1742-1241.2008.01891.x","article-title":"Guidelines on the diagnosis and treatment of pulmonary non-tuberculous mycobacteria infection","volume":"62","author":"McGrath","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0055","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1056\/NEJMoa1108789","article-title":"National survey of drug-resistant tuberculosis in China","volume":"366","author":"Zhao","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0060","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1471-2334-8-166","article-title":"Prevalence of tuberculosis drug resistance in 10 provinces of China","volume":"8","author":"He","year":"2008","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0065","first-page":"184","article-title":"Nontuberculous mycobacteria: susceptibility pattern and prevalence rate in Shanghai from 2005 to 2008","volume":"123","author":"Wang","year":"2010","journal-title":"Chin Med J"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0070","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3201\/eid1803.110175","article-title":"Prevalence of nontuberculous mycobacteria infection, China, 2004\u20132009","volume":"18","author":"Jing","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0075","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3201\/eid2007.131801","article-title":"Prevalence and drug resistance of nontuberculous mycobacteria, northern China, 2008\u20132011","volume":"20","author":"Wang","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0080","doi-asserted-by":"crossref","first-page":"e0003623","DOI":"10.1371\/journal.pntd.0003623","article-title":"The epidemiology and geographic distribution of nontuberculous mycobacteria clinical isolates from sputum samples in the eastern region of China","volume":"9","author":"Shao","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0085","series-title":"Susceptibility testing of mycobacteria, Nocardiae, and other aerobic actinomycetes; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2011"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0090","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1128\/JCM.41.4.1637-1650.2003","article-title":"PCR-based method to differentiate the subspecies of the Mycobacterium tuberculosis complex on the basis of genomic deletions","volume":"41","author":"Huard","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0095","series-title":"Susceptibility testing of mycobacteria, Nocardiae, and other aerobic actinomycetes; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2003"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0100","series-title":"Updated critical concentrations for first-line and second-line DST (as of May 2012)","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0105","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1128\/AAC.34.7.1453","article-title":"In vitro susceptibilities of oxacillin-resistant Staphylococcus aureus to dapsone and sulfamethoxazole alone and in combination with trimethoprim","volume":"34","author":"Lambertus","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0110","first-page":"933","article-title":"In vitro activity of thiacetazone on mycobacterial species belonging to the Mycobacterium tuberculosis complex","volume":"6","author":"Abate","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0115","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijantimicag.2009.12.008","article-title":"High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria","volume":"35","author":"Shen","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0120","doi-asserted-by":"crossref","first-page":"502","DOI":"10.5588\/ijtld.10.0238","article-title":"Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis","volume":"15","author":"Schon","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0125","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1164\/rccm.200509-1531OC","article-title":"Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease","volume":"173","author":"Lam","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0130","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1086\/514748","article-title":"A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex","volume":"28","author":"Gordin","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0135","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/thx.2007.087999","article-title":"Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy","volume":"63","author":"Jenkins","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0140","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1346-8138.2007.00399.x","article-title":"Successful treatment of cutaneous Mycobacterium chelonae infection with roxithromycin","volume":"34","author":"Sodemoto","year":"2007","journal-title":"J Dermatol"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0145","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1128\/AAC.36.1.180","article-title":"Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms","volume":"36","author":"Brown","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0150","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1128\/AAC.33.9.1614","article-title":"In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex","volume":"33","author":"Naik","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0155","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijantimicag.2009.09.023","article-title":"In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands","volume":"35","author":"van Ingen","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0160","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1128\/AAC.00410-07","article-title":"In vitro and in vivo activities of novel fluoroquinolones alone and in combination with clarithromycin against clinically isolated Mycobacterium avium complex strains in Japan","volume":"51","author":"Kohno","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0165","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1164\/ajrccm.153.6.8665032","article-title":"Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients","volume":"153","author":"Wallace","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0170","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1128\/AAC.45.11.3056-3058.2001","article-title":"Rifampin resistance in Mycobacterium kansasii is associated with rpoB mutations","volume":"45","author":"Klein","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0175","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.meegid.2014.07.032","article-title":"Antimicrobial susceptibility and molecular characterization of Mycobacterium intracellulare in China","volume":"27","author":"Zhao","year":"2014","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0180","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1128\/AAC.01275-08","article-title":"A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae","volume":"53","author":"Nash","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.10.024_bib0185","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1128\/AAC.48.7.2415-2423.2004","article-title":"Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis","volume":"48","author":"Li","year":"2004","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857916303983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857916303983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T20:05:32Z","timestamp":1568664332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857916303983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0924857916303983"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.10.024","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}